Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lamotrigine in refractory partial and general epilepsies].

J A Mauri-Llerda1, C Tejero, F Espada

  • 1Servicio de Neurología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.

Revista De Neurologia
|April 11, 2001
PubMed
Summary

Lamotrigine (LTG) is an effective adjunctive therapy for refractory epilepsy, significantly reducing seizure frequency in most patients. This antiepileptic drug demonstrated good tolerability with minor side effects in a large adult study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of new technologies on neurology in Spain. Review by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology.

Neurologia·2022
Same author

The burden of heat-related mortality attributable to recent human-induced climate change.

Nature climate change·2021
Same author

[Emergency department management of epileptic seizures in patients with epilepsy].

Revista de neurologia·2021
Same author

Impact of new technologies on neurology in Spain. Review by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology.

Neurologia·2020
Same author

Seasonality of suicide: a multi-country multi-community observational study.

Epidemiology and psychiatric sciences·2020
Same author

Cuban Isolate of Bean golden yellow mosaic virus is a Member of the Mesoamerican BGYMV Group.

Plant disease·2019

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Lamotrigine (LTG) is an antiepileptic drug with proven efficacy in partial and generalized tonic-clonic seizures.
  • LTG demonstrates comparable efficacy to carbamazepine and phenytoin, but with fewer adverse events.

Purpose of the Study:

  • To evaluate the efficacy and safety of lamotrigine (LTG) as adjunctive therapy in adult patients with refractory epilepsy.
  • To assess the impact of LTG on seizure frequency and remission rates.

Main Methods:

  • A study involving 106 adult patients with refractory epilepsy receiving adjunctive LTG therapy.
  • Follow-up period extended up to 3.4 years, with an average LTG dose of 273 mg/day.

Main Results:

  • 66% of patients achieved at least a 50% reduction in seizure frequency; 30% experienced complete remission.

Related Experiment Videos

  • Significant seizure reductions were observed for partial, secondarily generalized, and generalized seizures.
  • LTG was well-tolerated, with minor side effects and no reported cases of rash.

    • Conclusions:

    • Lamotrigine is an excellent option for adjunctive therapy in patients with refractory epilepsy.
    • LTG offers a favorable efficacy and safety profile for managing difficult-to-treat seizure disorders.